CoChat

Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis

Open access
Peters, Ruth, Yasar, Sevil, Anderson, Craig S., Andrews, Shea, Antikainen, Riitta, Arima, Hisatomi, Beckett, Nigel, Beer, Joanne C., Bertens, Anne Suzanne, Booth, Andrew, van Boxtel, Martin, Brayne, Carol, Brodaty, Henry, Carlson, Michelle C., Chalmers, John, Corrada, Maria, DeKosky, Steven, Derby, Carol, Dixon, Roger A., Forette, Françoise, Ganguli, Mary, van Gool, Willem A., Guaita, Antonio, Hever, Ann M., Hogan, David B., Jagger, Carol, Katz, Mindy, Kawas, Claudia, Kehoe, Patrick G., Keinanen-Kiukaanniemi, Sirkka, Kenny, Rose Ann, Köhler, Sebastian, Kunutsor, Setor K., Laukkanen, Jari, Maxwell, Colleen, McFall, G. Peggy, van Middelaar, Tessa, Moll van Charante, Eric P., Ng, Tze-Pin, Peters, Jean, Rawtaer, Iris, Richard, Edo, Rockwood, Kenneth, Rydén, Lina, Sachdev, Perminder S., Skoog, Ingmar, Skoog, Johan, Staessen, Jan A., Stephan, Blossom C.M., Sebert, Sylvain, Thijs, Lutgarde, Trompet, Stella, Tully, Phillip J., Tzourio, Christophe, Vaccaro, Roberta, Vaaramo, Eeva, Walsh, Erin, Warwick, Jane, Anstey, Kaarin J. · 2020 · Neurology
Cited by 153

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: High blood pressure is one of the main modifiable risk factors for dementia. However, there is conflicting evidence regarding the best antihypertensive class for optimizing cognition. Our objective was to determine whether any particular antihypertensive class was associated with a reduced risk of cognitive decline or dementia using comprehensive meta-analysis including reanalysis of original participant data. METHODS: To identify suitable studies, MEDLINE, Embase, and PsycINFO and preexisting study consortia were searched from inception to December 2017. Authors of prospective longitudinal human studies or trials of antihypertensives were contacted for data sharing and collaboration. Outcome measures were incident dementia or incident cognitive decline (classified using the reliable change index method). Data were separated into mid and late-life (>65 years) and each antihypertensive class was compared to no treatment and to treatment with other antihypertensives. Meta-analysis was used to synthesize data. RESULTS: Over 50,000 participants from 27 studies were included. Among those aged >65 years, with the exception of diuretics, we found no relationship by class with incident cognitive decline or dementia. Diuretic use was suggestive of benefit in some analyses but results were not consistent across follow-up time, comparator group, and outcome. Limited data precluded meaningful analyses in those ≤65 years of age. CONCLUSION: Our findings, drawn from the current evidence base, support clinical freedom in the selection of antihypertensive regimens to achieve blood pressure goals. CLINICAL TRIALS REGISTRATION: The review was registered with the international prospective register of systematic reviews (PROSPERO), registration number CRD42016045454.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000008732

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 153

Metadata

Authors
Peters, R., Yasar, S., Anderson, C. S., Andrews, S., Antikainen, R., Arima, H., Beckett, N., Beer, J. C., Bertens, A. S., Booth, A., van Boxtel, M., Brayne, C., Brodaty, H., Carlson, M. C., Chalmers, J., Corrada, M., DeKosky, S., Derby, C., Dixon, R. A., Forette, F., Ganguli, M., van Gool, W. A., Guaita, A., Hever, A. M., Hogan, D. B., Jagger, C., Katz, M., Kawas, C., Kehoe, P. G., Keinanen-Kiukaanniemi, S., Kenny, R. A., Köhler, S., Kunutsor, S. K., Laukkanen, J., Maxwell, C., McFall, G. P., van Middelaar, T., Moll van Charante, E. P., Ng, T.-P., Peters, J., Rawtaer, I., Richard, E., Rockwood, K., Rydén, L., Sachdev, P. S., Skoog, I., Skoog, J., Staessen, J. A., Stephan, B. C. M., Sebert, S., Thijs, L., Trompet, S., Tully, P. J., Tzourio, C., Vaccaro, R., Vaaramo, E., Walsh, E., Warwick, J., & Anstey, K. J.
Venue
Neurology
Published
2020-01-21
Volume
94
Issue
3
Pages
e267-e281
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2963287234
Cited by
153
References
16
FWCI
16.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. https://app.cochat.ai/papers/10.1212/wnl.0000000000008732
The paper
Peters, R., Yasar, S., Anderson, C. S., Andrews, S., Antikainen, R., Arima, H., Beckett, N., Beer, J. C., Bertens, A. S., Booth, A., van Boxtel, M., Brayne, C., Brodaty, H., Carlson, M. C., Chalmers, J., Corrada, M., DeKosky, S., Derby, C., Dixon, R. A., . . . Anstey, K. J. (2020). Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. Neurology. https://doi.org/10.1212/wnl.0000000000008732

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.